Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
106.2 USD | +0.50% | +0.19% | -3.54% |
Apr. 29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
Apr. 26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.54% | 185B | |
-0.58% | 109B | |
-2.74% | 68.54B | |
+4.84% | 51.74B | |
+10.40% | 45.22B | |
+3.12% | 41.74B | |
+2.87% | 26.69B | |
+4.61% | 26.83B | |
+11.62% | 25.63B | |
-0.22% | 24.98B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Earnings Flash (ABT) ABBOTT Posts Q1 EPS $0.98, vs. Street Est of $0.95